TAF15 in tumor-associated macrophages enhances protumorigenic polarization and promotes cholangiocarcinoma progression

Our study provides the first evidence that TATA-binding protein-associated factor 15 regulates tumor-associated macrophages polarization through the SOCS1/JAK2/STAT1 axis, unveiling a novel immunotherapeutic target for cholangiocarcinoma. The developed M2pep-LNP-siTAF15 nanodelivery system not only overcomes the challenge of targeted delivery, but its remarkable antitumor efficacy highlights strong potential for clinical translation. This work fundamentally advances our understanding of stromal-immune crosstalk in cholangiocarcinoma while offering a clinically actionable therapeutic strategy.

Authors

Institutions

Publication Details

Journal
JHEP Reports
Published
2025-08-12
DOI
https://doi.org/10.1016/j.jhepr.2025.101545
Primary Topic
Peptidase Inhibition and Analysis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

TAF15 in tumor-associated macrophages enhances protumorigenic polarization and promotes cholangiocarcinoma progression

Jingjing Wei, Hong‐Wen Liu, Suzhen Yang, Lin Zhou et al.
JHEP Reports
Peptidase Inhibition and Analysis
article

TAF15 in tumor-associated macrophages enhances protumorigenic polarization and promotes cholangiocarcinoma progression

Jingjing Wei, Hong‐Wen Liu, Suzhen Yang, Lin Zhou, Shanshan Shen, Tianming Zhao, Ge Bai, Yun Zhu, Zhangding Wang, Yu Liu, Lei Wang, Lei Wang, Lei Xu, Bing Xu, Nannan Zhang, Xin Fu, Zhao Si, Qi Chen, Yu‐Guang Zhou, Yue Zhou, Yani Pan
article en

Abstract

Our study provides the first evidence that TATA-binding protein-associated factor 15 regulates tumor-associated macrophages polarization through the SOCS1/JAK2/STAT1 axis, unveiling a novel immunotherapeutic target for cholangiocarcinoma. The developed M2pep-LNP-siTAF15 nanodelivery system not only overcomes the challenge of targeted delivery, but its remarkable antitumor efficacy highlights strong potential for clinical translation. This work fundamentally advances our understanding of stromal-immune crosstalk in cholangiocarcinoma while offering a clinically actionable therapeutic strategy.

JHEP ReportsVol. 7(12)
Nanjing University of Chinese Medicine (CN), Nanjing Drum Tower Hospital (CN)
National Natural Science Foundation of China, Jiangsu Provincial Key Research and Development Program, Key Project of Science and Technology Development of Nanjing Medicine, Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau
Openalex Percentile: Top 70%
Peptidase Inhibition and Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.